The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic... - 0 views
-
orally active competitive opioid receptor antagonist
-
4.5 mg, though the dosage can vary a few milligrams below or above that common value
-
At the low dosage level, naltrexone exhibits paradoxical properties, including analgesia and anti-inflammatory actions
- ...10 more annotations...